NDA 005657

BRISTOL MYERS SQUIBB

FDA Drug Application

Application #005657

Application Sponsors

NDA 005657

BRISTOL MYERS SQUIBB

Marketing Status

• Discontinued: 001

Application Products

001

INJECTABLE;INJECTION

3MG/ML

0

TUBOCURARINE CHLORIDE

TUBOCURARINE CHLORIDE

FDA Submissions

TYPE 1; Type 1 - New Molecular Entity	ORIG	1	AP	1945-02-20	PRIORITY
LABELING; Labeling	SUPPL	2	AP	1976-12-16	PRIORITY
LABELING; Labeling	SUPPL	3	AP	1977-02-16	PRIORITY
LABELING; Labeling	SUPPL	4	AP	1980-04-29	PRIORITY
MANUF (CMC); Manufacturing (CMC)	SUPPL	5	AP	1980-07-28	PRIORITY
LABELING; Labeling	SUPPL	6	AP	1985-08-19	PRIORITY
MANUF (CMC); Manufacturing (CMC)	SUPPL	7	AP	1985-07-22	PRIORITY
MANUF (CMC); Manufacturing (CMC)	SUPPL	8	AP	1986-11-14	PRIORITY
LABELING; Labeling	SUPPL	9	AP	1987-06-10	PRIORITY
MANUF (CMC); Manufacturing (CMC)	SUPPL	10	AP	1992-11-06	PRIORITY

Submissions Property Types

ORIG	1	Null	0
SUPPL	2	Null	0
SUPPL	3	Null	0
SUPPL	4	Null	0
SUPPL	5	Null	0
SUPPL	6	Null	0
SUPPL	7	Null	0
SUPPL	8	Null	0
SUPPL	9	Null	0
SUPPL	10	Null	0

CDER Filings

BRISTOL MYERS SQUIBB

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 5657
            [companyName] => BRISTOL MYERS SQUIBB
            [docInserts] => ["",""]
            [products] => [{"drugName":"TUBOCURARINE CHLORIDE","activeIngredients":"TUBOCURARINE CHLORIDE","strength":"3MG\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"TUBOCURARINE CHLORIDE","submission":"TUBOCURARINE CHLORIDE","actionType":"3MG\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)